The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

Buku Lengkap GARIS PANDUAN PPDa SMK MATUPANG JAYA

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by jempurungjebert, 2023-08-09 11:33:53

Buku Lengkap GARIS PANDUAN PPDa SMK MATUPANG JAYA

Buku Lengkap GARIS PANDUAN PPDa SMK MATUPANG JAYA

104 KOMPONEN 3 ISI KANDUNGAN PENGURUSAN DATA PPDa Mengumpul Data Mengenal Pasti Murid Terlibat Dadah, Alkohol, Rokok, Inhalan, HIV/ AIDS dan Bahan Terlarang yang Lain 3.1 Melaksanakan Soal Selidik Menggunakan Borang Soal Selidik B4 Versi 2.0 3.2 Menganalisis Data dan Menyediakan Rumusan Borang Soal Selidik B4 Menggunakan Borang B5 3.3 Membentang Rumusan Analisis Data Soal Selidik Dalam Mesyuarat Pengurusan Sekolah 3.4 Melaksanakan Intervensi Menganalisis, Merekod dan Menghantar Pelaporan PPDa kepada PPD 3.5 Borang Pelaporan Aktiviti PPDa SM 01/ SR 01 3.6 Borang B5 KOMPONEN 4 ISI KANDUNGAN Pelaksanaan Ujian Saringan Urin 4.1 Surat Pelaksanaan Ujian Saringan Urin 4.2 Senarai Murid yang Terlibat Dengan Ujian Saringan Urin (Borang B1) 4.3 Keputusan Ujian Saringan Urin PENGURUSAN Kandungan Fail Intervensi Murid Positif Ujian Saringan Urin PENDIDIKAN 4.4 Profil Murid Positif Ujian Saringan Urin (Borang B2) INTERVENSI 4.5 Salinan Maklumat Diri Murid (APDM) (FAIL SULIT) 4.6 Salinan Surat Keputusan Ujian Saringan Urin AADK 4.7 Salinan Slip Kemajuan Akademik (SAPS) – Disahkan 4.8 Salinan Analisis Kehadiran Bulanan Murid – Disahkan 4.9 Rekod Seliaan Kaunseling (Borang B3) 4.10 Rekod Aku Janji Murid/ Ibubapa/ Penjaga - Ditandatangan


105 7 NO. TELEFON & FAKS 4 LOKASI SEKOLAH 6 SEKOLAH BERASRAMA INSTRUMEN PEMANTAUAN PENGURUSAN PPDa DI SEKOLAH 1 NAMA SEKOLAH 2 KOD SEKOLAH 3 GRED SEKOLAH 5 ALAMAT SEKOLAH 8 NAMA PENGETUA/ GURU BESAR 9 NAMA GURU PPDa SEKOLAH DAN NO. TELEFON 10 BIL. GURU L P JUMLAH 11 BIL. MURID L P JUMLAH 12 TARIKH PEMANTAUAN 13 CAP NAMA, JAWATAN & TANDATANGAN PEMANTAU 1 PEMANTAU 2 TARAF DESKRIPSI SKOR Cemerlang Kekuatan keseluruhan yang sangat jelas dan mempunyai nilai tambah untuk mendapat pengiktirafan serta boleh menjadi contoh kepada sekolah lain 3 Baik Banyak kekuatan yang jelas dan memenuhi/ melebihi keperluan minimum 2 Lemah Sedikit kekuatan tetapi ada kelemahan untuk tindakan pembetulan segera 1 Sangat Lemah Banyak kelemahan yang memerlukan tindakan pembetulan segera 0 Y (Ada) Banyak kekuatan yang jelas dan memenuhi/ melebihi keperluan minimum 3 T (Tiada) Banyak kelemahan yang memerlukan tindakan pembetulan segera 0 TB (Tidak Berkaitan) Sila tandakan TB di bahagian skor 3 atau Y bagi aspek dinilai yang tidak perlu atau tiada keperluan untuk dilaksanakan di sekolah 3 BD (Belum Dilaksanakan) Sila tandakan BD di bahagian skor 3 atau Y bagi aspek yang belum dilaksanakan di sekolah 3 YA TIDAK PEDALAMAN BANDAR LUAR BANDAR


106 PENILAIAN ASPEK PENGURUSAN PPDa KOMPONEN 1 ASPEK DINILAI SKOR Y T 0 1 2 3 PENGURUSAN DAN KEPIMPINAN Pengurusan Organisasi 1.1 Visi dan Misi Unit PPDa 1.2 Carta Organisasi Jawatankuasa Induk PPDa 1.3 Carta Organisasi Jawatankuasa Pelaksana PPDa 1.4 Carta Organisasi Bilik Sumber/ Laluan PPDa 1.5 Carta Organisasi Jawatankuasa Murid 1.6 Rancangan Tahunan/ Takwim PPDa Sekolah 1.7 Minit Mesyuarat Jawatankuasa PPDa 1.8 Surat Siaran/ Pekeliling Ikhtisas PPDa Borang/ Instrumen Penilaian dan Pelaporan PPDa Y T 0 1 2 3 1.9 Instrumen Penilaian Penarafan Bilik Sumber/ Laluan PPDa Sekolah 1.10 Borang Pelaporan Aktiviti PPDa SM 01/ SR 01 1.11 Garis Panduan Pelaksanaan Pendidikan Pencegahan Dadah di Sekolah Buku/ Bahan Rujukan dan Panduan Pelaksanaan PPDa Y T 0 1 2 3 1.12 Modul Intervensi PPDa di Sekolah 1.13 Buku Mesej 5 Minit PPDa JUMLAH SKOR (39) KOMPONEN 2 ASPEK DINILAI SKOR Y T 0 1 2 3 PENGURUSAN PENDIDIKAN PENCEGAHAN Merancang, Melaksana dan Merekodkan Program Teras PPDa (Kurikulum dan Kokurikulum) di Sekolah 2.1 Program Mesej 5 Minit PPDa 2.2 Sambutan Minggu/ Bulan Antidadah Sekolah 2.3 PPDa Merentasi Kurikulum 2.4 Skim Lencana Anti Dadah 2.0 (SLAD 2.0) - Pilihan 2.5 Bilik Sumber/ Laluan PPDa 2.6 Program Bersama-sama Agensi Luar Sila nyatakan : ............................................................ 2.7 Membaca Perutusan dan Ikrar Antidadah JUMLAH SKOR (21)


107 KOMPONEN 3 ASPEK DINILAI SKOR Y T 0 1 2 3 PENGURUSAN PEMBANGUNAN SAHSIAH MURID Menganalisis, Merekod dan Menghantar Laporan Data PPDa kepada PPD / JPN 3.1 Melengkapkan dan Menghantar Borang Pelaporan Aktiviti PPDa SM 01/SR 01 kepada PPD (dua kali setahun) Mengumpul dan Menganalisis Data Murid Menggunakan Borang B4 Versi 2.0 (Sekolah Menengah Sahaja) Y T 0 1 2 3 3.2 Melaksanakan Soal Selidik Menggunakan Borang B4 Versi 2.0 3.3 Menganalisis Data dan Menyediakan Rumusan Borang B4 Versi 2.0 Menggunakan Borang B5 Rekod Murid Berisiko Y T 0 1 2 3 3.4 Senarai Nama Murid Berisiko 3.5 Senarai Nama Murid yang Menjalani Ujian Saringan Urin (Borang B1) 3.6 Ujian Saringan Urin Murid Rekod Kaunseling Murid Berisiko/ Masalah Dadah Y T 0 1 2 3 3.7 Senarai Nama Murid (Borang B2) 3.8 Rekod Kaunseling Murid (Borang B3) JUMLAH SKOR (24) PENGUKURAN SKOR ASPEK PENILAIAN PPDa BIL ASPEK PENILAIAN MARKAH PENUH MARKAH DIPEROLEH PERATUS 1 Pengurusan dan Kepimpinan 39 2 Pengurusan Pendidikan Pencegahan (Kurikulum dan Kokurikulum) 21 3 Pengurusan Pembangunan Sahsiah Murid 24 JUMLAH 84 /100 PETUNJUK PRESTASI (% SKOR) TAHAP 0 - 39 LEMAH 40 - 65 SEDERHANA 63 - 75 HARAPAN 76 - 89 CEMERLANG 90 - 100 GEMILANG KEPUTUSAN


108 Lampiran ‘A’ Jadual Pertama Akta Dadah Berbahaya 1952 (Pindaan 1980 dan 1998) (First Schedule of Dangerous Drugs Act 1952) FIRST SCHEDULE [Sections 2, 11 (1) and 17 (3)] PART I Raw Opium (Candu Mentah) Coca Leaves (Daun Koka) Poppy-Straw Cannabis (Ganja) PART II Prepared Opium (Candu Masak) Cannabis (Ganja) Cannabis resin and substances of which such resin forms the base PART III Acetorphine Acetyl-alpha-methylfentanyl Acetylfentanyl Acetylmethadol Alfentanil Allylprodine Alphacetylmethadol Alphameprodine Alphamethadol Alpha-methylfentanyl Alpha-methylthiofentanyl Alphaprodine 2-amino-1-(2, 5-dimethoxy-4-methyl) phenylpropane Amphetamine Anileridine


109 Benzethidine Benzylmorphine Betacetylmethadol 8-beta-11-dihydroxy-delta-9-tetrahydroxycannabinol 8-beta-hydroxy-delta-9-tetrahydrocannabinol Beta-hydroxyfentanyl Betahydroxy-3-methylfentanyl Betameprodine Betamethadol Betaprodine Bezitramide Butorphanol Butyrfentanyl 4-bromo-2, 5-dimethoxyphenylethylamine (2C-B) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe) Cathinone 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe) Clonitazene Cocaine Codoxime Concentrate of poppy-straw (the material arising when poppy-straw has entered into a process for the concentration of its alkaloids, when such material is made available in trade) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) delta-8-tetrahydrocannabinol delta-9-tetrahydrocannabinol Desomorphine DET, N, N-diethyltryptamine Dextromoramide Diampromide 3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide (AH-7921) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-7700) Diethylthiambutene


Difenoxin Dihydroetorphine Dihydromorphine Dimenoxadol Dimepheptanol 2, 5-Dimethoxyamphetamine (DMA) Dimethoxybromoamphetamine (DOB) 2, 5-Dimethoxy-4-ethylamphetamine (DOET) Dimethylthiambutene Dioxaphetyl butyrate Diphenoxylate Dipipanone DMHP, 3-(1, 2-dimethylheptyl)-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl 6H-dibenzo [b, d] pyran DMT, N. N-dimethyltryptamine Drotebanol Ecgonine Ethylmethylthiambutene Eticyclidine, N-ethyl-l-phenylcyclohexyl-amine Etonitazene Etorphine Etoxeridine Etryptamine Extract or tincture of cannabis Extract or tincture of coca leaves Extract or tincture of opium Fentanyl Flunitrazepam Furethidine Gamma hydroxybutyric acid (GHB) Heroin Hydrocodone Hydromorphinol Hydromorphone 11-hydroxy-delta-8-tetrahydrocannabinol 110


11-hydroxy-delta-9-tetrahydrocannabinol Hydroxypethidine 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe) Isomethadone Ketamine Ketobemidone Levomethorphan Levomoramide Levophenacylmorphan Levorphanol (+)-Lysergide, (+)-N-N-diethyllysergamide (d-lysergic acid diethylamide) Mescaline, 3, 4, 5-trimethoxyphenethylamine Metazocine Methadone Methadone-Intermediate Methamphetamine Methcathinone 5-Methoxy-3, 4-methylenedioxyamphetamine (MMDA) 4-methylaminorex Methyldesorphine Methyldihydromorphine Methylenedioxy-amphetamine (MDA) 3, 4-Methylenedioxymethamphetamine (MDMA) 3-methylfentanyl 1-methyl-4-phenyl-4-piperidinol propionate (MPPP) 3-methylthiofentanyl 4-methylthioamphetamine (4-MTA) Metopon Monoacetylmorphines Moramide-Intermediate Morpheridine Morphine Morphine Methobromide and other pentavalent nitrogen morphine derivatives, including in particular the morphine-N-oxide derivatives, one of which is Codeine N-oxide Morphine-N-oxide 111


Myrophine N-ethyl MDA N-hydroxy MDA N-methyl-1-(3, 4-methylenedioxyphenyl)-2-butanamine Nicomorphine Nimetazepam Noracymethadol 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid Norlevorphanol Normethadone Normorphine Norpipanone Oxycodone Oxymorphone Para-fluorofentanyl Parahexyl, 3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] pyran Paramethoxyamphetamine (PMA) Para-methoxymethylamphetamine (PMMA) Pethidine Pethidine-Intermediate—A Pethidine-Intermediate—B Pethidine-Intermediate—C Phenadoxone Phenampromide Phenazocine 1-phenethyl-4-phenyl-4-piperidinol acetate (PEPAP) Phenomorphan Phenoperidine Piminodine Piritramide Propheptazine Properidine Psilocine, Psilotsin, 3-(2-dimethylaminoethyl)-4-hydroxyindole Psilocybine, 3-(2-dimethylaminoethyl)-indol-4-yl dihydrogen phosphate Racemothorphan 112


Racemoramide Racemorphan Remifentanil Rolicyclidine, I-(1-phenylcyclohexyl) pyrrolidine Sufentanil Tenocyclidine, 1-[1-(2-thienyl) cyclohexyl] piperidine Tetrahydrocannabinols, 1-hydroxy-3-pentyl-6a,7,10, 10a-tetrahydro-6, 6, 9 trimethyl-6-H-dibenzo [b, d] pyran Thebacon Thebaine Thiofentanyl Tilidine Trimeperidine 3, 4, 5-Trimethoxyamphetamine (3, 4, 5-TMA) The isomers, unless specifically excepted, of the drugs in this Part whenever the existence of such isomers is possible within the specific chemical designation; The esters and ethers, unless appearing in another Part, of the drugs in this Schedule whenever the existence of such esters or ethers is possible; The salts of the drugs listed in this Part, including the salts of esters, ethers and isomers as provided above whenever the existence of such salts is possible. Acetyldihydrocodeine Codeine Dextropropoxyphene Dihydrocodeine Ethylmorphine Nicocodine Nicodicodine Norcodeine Pholcodine Propiram PART IV The isomers, unless specifically excepted, of the drugs in this Part whenever the existence of such isomers is possible within the specific chemical designation; The salts of the drugs listed in this Part, including the salts of the isomers as provided above whenever the existence of such salts is possible. 113


114 PART V PREPARATION FOR THE EXPORT OF WHICH EXPORT AUTHORIZATIONS ARE NOT REQUIRED 1. Deleted by P.U. (A) 151/2001. 2. Preparations of cocaine containing not more than 0.1 per cent of cocaine calculated as cocaine base and preparations of opium or morphine containing not more than 0.2 per cent of morphine calculated as anhydrous morphine base and compounded with one or more other ingredients and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health. 3. Preparations of diphenoxylate containing, per dosage unit, not more than 2.5 milligrammes of diphenoxylate calculated as base and a quantity of atropine sulphate equivalent to at least 1 per cent of the dose of diphenoxylate. 4. Pulvis ipecacuanhae et opil compositus 10 per cent opium in powder 10 per cent ipecacuanha root, in powder well mixed with 80 per cent of any other powdered ingredient containing no drug. 4A. Preparations of difenoxin containing, per dosage unit, not more than 0.5 milligrammes of difenoxin and a quantity of atropine sulphate equivalent to at least 5 per cent of the dose of difenoxin. 4B. Preparations for oral use containing not more than 150 milligrammes of dextropropoxyphene salts per dosage unit or with a concentration of not more than 2.5 per cent in undivided preparations. 5. Preparations conforming to any of the formulae listed in this Part and mixtures of such preparations with any material which contains no drug. Akta Dadah Berbahaya 1952 memberi peruntukan kepada Menteri yang bertanggungjawab bagi perkhidmatan perubatan dan kesihatan bagi menambah ke dalam senarai dalam Jadual Pertama mana-mana dadah-dadah lain seperti dikehendaki oleh Akta A330 Akta Dadah Berbahaya (Pindaan) 1976. (dapatkan maklumat terkini dari AADK)


115 LAGU : TEMA PPDa Hidup Cemerlang Tanpa Dadah Usah biarkan masa berlalu pergi Dalam meniti ranjau berduri Wawasan negara kekal waja bina bersama Harapan Semua .. Anak-anak Bangsa Kami Sihat Kami Hebat Kami Kuat Kami Tekad Tanpamu, Hidup Bebas Merdeka Tanpamu, Hidup Riang Cemerlang Tanpamu, Nusa Bangsa Gemilang Tanpamu. Negara Pasti Terbilang Kita Bersatu Kita Berpadu Katakan .. Laungkan .. Kami Bebas Dari Dadah


116 GLOSARI Agensi Antidadah Kebangsaan (AADK) Bahagian Narkotik Polis DiRaja Malaysia (PDRM) Drugs Free Youth Association (DFYA) Guru Bimbingan dan Kaunseling (GBK) Jabatan Kebajikan Masyarakat (JKM) Jabatan Pendidikan Negeri (JPN) Kementerian Belia Dan Sukan (KBS) Kementerian Kesihatan Malaysia (KKM) Kementerian Pendidikan Malaysia (KPM) Majlis Keselamatan Negara (MKN) Pejabat Pendidikan Daerah (PPD) PPDa (PPDa) Pelibatan Ibu Bapa dan Komuniti (PIBK) Persatuan Ibu bapa Guru (PIBG) Persatuan Mencegah Dadah Malaysia (PEMADAM) Yayasan Pencegahan Jenayah Malaysia


Click to View FlipBook Version